Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma.
Recent reports have suggested the presence of oestrogen receptors (ER) in pancreatic carcinoma. Therefore the tumour may be sensitive to hormone manipulation therapy. We examined 23 biopsies of human pancreatic carcinoma tissue for the presence of ER. The tissue was assayed by two methods: Iso-electric focusing (IEF) and ER-ICA an immunocytochemical assay. All biopsies were tested with ER-ICA and ten by IEF. Each biopsy was assessed histologically for tumour content and 20 contained adenocarcinoma. None of the samples of pancreatic carcinoma were positive for ER using the ER-ICA, and none demonstrated the binding peak typical of ER in the IEF assay. These results suggest that in pancreatic carcinoma oestrogen receptor is either absent (or at very low levels), or of a different type to that found in breast and uterine tissue. On theoretical grounds at least, this must raise questions as to the oestrogen sensitivity of pancreatic cancer.
Taylor
O M
OM
Department of Surgery, General Infirmary, Leeds, UK.
Teasdale
J
J
Cowen
P N
PN
McMahon
M J
MJ
Benson
E A
EA
D000230:Adenocarcinoma / Q000737:chemistry*; D006801:Humans; D007124:Immunoenzyme Techniques; D007525:Isoelectric Focusing; D010190:Pancreatic Neoplasms / Q000737:chemistry*; D011960:Receptors, Estrogen / Q000032:analysis*
D011960:Receptors, Estrogen